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ABSTRACT
Objective: To assess the efficacy of a proprietary blend rich in glycoside based standardized fenugreek seed extract (400 mg) and minor quantities 
of curcumin and cinnamon (25 mg each) supplementation (IBPR) on inflammatory markers related to skeletal muscle soreness using double-blind 
placebo control, parallel design.
Methods: A total of 20 healthy non-resistance trained young male and female subjects were assigned to ingest either IBPR or matching placebo for 
14 days before the eccentric exercise bout. Subjects were instructed to perform 24 sets with 10 eccentric knee extensor repetitions (with one leg at 
30°/s on an isokinetic device). Subjects had their blood drawn at baseline, immediately post, 1 hr, 3 hrs, and 24 hrs post-eccentric exercise. Efficacy 
in terms of serum levels of anti-inflammatory cytokines interleukin-10 (IL-10), pro-inflammatory cytokines (IL-1ra, IL-1b, IL-6, and tumor necrosis 
factor) and safety in terms of kidney function (blood urea nitrogen (BUN), serum creatinine, BUN to creatinine ratio), and differential leukocyte count 
were measured. The data of each parameter were analyzed by two-way repeated measure ANOVA.
Results: Significant time-dependent effects were observed in IL1b, IL6, and creatinine values from baseline whereas significant treatment dependent 
effect was seen in IL-1ra. IBPR was found to be safe and well tolerated.
Conclusion: IBPR supplementation showed a significant anti-inflammatory efficacy on eccentric exercise-induced inflammatory markers of skeletal 
muscle soreness in non-resistance trained subjects.
Keywords: Fenugreek glycosides, Inflammation markers, Eccentric exercise.
INTRODUCTION
Resistance exercise (RX) promotes muscle strength, physical 
performance, and healthy living [1]. There are two phases (concentric 
and eccentric) of muscle contraction during RX. During the eccentric 
phase of muscle contractions, skeletal muscles generate higher forces. 
Eccentric muscle actions are essential in performing normal daily 
activities and physical activities such as stair climb and descent, body 
transfers, and balance tasks [2]. Eccentric actions occur during sports 
activities such as running and walking. Eccentric strength is also 
necessary for retaining functional independence with aging [1].
Eccentric exercise is linked to several health-promoting adaptations. 
For example, chronic eccentric exercise elicits many beneficial effects, 
such as favorable changes in blood lipid profile [3,4], improved oxidative 
stress status [5], and improved insulin sensitivity [6]. Eccentric exercise 
also has beneficial effects on inflammatory status. Although the 
eccentric exercise-induced muscle micro damage acutely up-regulates 
proinflammatory/pro-oxidant agents (e.g., increased interleukin [IL-6]), 
chronically over a longer term, it down-regulates proinflammatory/
pro-oxidant agents and up-regulates anti-inflammatory/antioxidant 
agents (e.g., increased IL-10; [7]). Eccentric exercise causes greater 
increases in muscle strength and the muscle soreness as compared to 
concentric exercise due to the greater muscle hypertrophy that follows 
eccentric training compared to concentric [8,9].
Preclinical studies showed the evidence of anti-inflammatory activity in 
decreasing inflammatory cytokine levels associated with fenugreek seed 
extract [10,11]. Fenugreek (Trigonella foenum-graecum) is a leguminous, 
annual plant found in India and North Africa. Fenugreek seed is part of 
diets of various countries and is now cultivated worldwide. It is a source 
of many natural products with health benefits [12]. Many natural 
products extract or powders that are formulated for medicinal and 
supplementation applications contain fenugreek seeds and leaves [13]. 
Fenugreek extract and supplementation has been studied extensively 
in human and animal models. Defatted fractions of fenugreek seeds 
(high in fiber content and containing steroidal saponins) are reported 
to lower blood glucose and plasma glucagon concentrations after 
8 days of consumption in dogs [14]. Other investigations are utilizing 
human participants on fenugreek supplementation (daily doses of 
1-25 g/day) by diabetic patients showed positive glucose regulation 
responses [15,16]. Anti-inflammatory activity of many glycosides 
from various plant extracts has been reported [17-19]. Therefore, it 
was thought worthwhile to explore a glycoside based standardized 
fenugreek seed extract against inflammatory markers in healthy human 
subjects during eccentric exercise using double-blind placebo control 
study design.
However, a glycoside based standardized fenugreek seed extract has 
the characteristic smell of fenugreek seeds. Therefore, to maintain the 
double-blind, placebo control design of the study, minor quantities of 
curcumin and cinnamon (25 mg) were added to make a proprietary 
blend, IBPR. These added quantities of curcumin [20] and cinnamon [21] 
were below reported efficacious doses and durations against 
inflammatory markers and so nonactive. The objective of the study was 
to evaluate the anti-inflammatory effect of IBPR supplementation, a 
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proprietary blend rich in glycoside-based standardized fenugreek seed 
extract (400 mg) and minor quantities (25 mg each) of curcumin and 




A total of 20 non-resistance-trained (<6 months) male and female 
participants assigned to ingested either IBPR, (n=10, age: 21±2.8 years, 
height: 174±10 cm, weight: 77±20 kg) or matching placebo (n=10, age: 
20±1.9 years, height: 175±14 cm, weight: 89±20 kg) participated in this 
study. Following types of subjects were excluded from participation 
in this study: (a) With any metabolic disorder (known electrolyte 
abnormalities, heart disease, arrhythmias, diabetes, thyroid disease, 
or hypogonadism), (b) with a history of hypertension, hepatorenal, 
musculoskeletal, autoimmune, or neurologic disease, (c) those taking 
thyroid, hyperlipidemic, hypoglycemic, antihypertensive, or androgenic 
medications, and (d) if they have taken ergogenic levels of nutritional 
supplements that may affect muscle mass (e.g., creatine, beta-hydroxy 
beta-methylbutyric acid or anabolic/catabolic hormone levels 
androstenedione, and dehydroepiandrosterone) within 6 months 
before the start of the study. Institutional review board approved the 
study protocol as per human subjects Guidelines of University of Mary 
Hardin-Baylor University, USA. The subjects meeting eligibility criteria 
were informed of the requirements of the study and sign the statements 
of informed consent in compliance with the human subjects Guidelines 
of University of Mary Hardin-Baylor University, USA, and the American 
College of Sports Medicine, USA.
Supplementation
Subjects were randomized into either active supplementation (IBPR) or 
matching placebo. IBPR is a proprietary blend rich in glycoside based 
standardized fenugreek seed extract (400 mg) and minor quantities 
of curcumin and cinnamon (25 mg each). Subjects were randomly 
assigned to ingest 450 mg of IBPR or matching placebo. Subjects 
were ingested 2 capsules of assigned treatment for 14 days before the 
eccentric exercise. The supplements were prepared in capsule form and 
packaged in plastic bottles for double-blind administration by Indus 
Biotech Private Limited, Pune, India. Research assistants at the study 
center monitored the compliance.
Experimental design
The study was conducted as a double-blind, placebo-controlled 
clinical trial using parallel groups matched based on free fat mass. The 
independent variables were the nutritional supplements. Blood profiles 
including; inflammatory markers (IL-6, IL-1b, IL-10, IL-1ra, and tumor 
necrosis factor [TNF-α]), markers of muscle soreness [creatinine, 
blood urea nitrogen (BUN) to creatinine ratio], and safety parameters 
(neutrophils, eosinophils, basophils, lymphocytes, and monocytes) 
were measured. Subjects were randomly placed into one of two groups: 
IBPR or Placebo.
Entry and familiarization session
Subjects with interest of participation in this study were interviewed 
on the phone to determine they qualify to participate in this study and 
were invited to attend an entry/familiarization session. During this 
session, subjects signed informed consent statements and complete 
personal and medical histories. Subjects were undergone a general 
physical examination to check that they meet eligibility criteria. 
Subjects meeting entry criteria were familiarized to the study protocol 
via a verbal and written explanation outlining the study design. 
Subjects were given an appointment time to perform baseline/pre-
supplementation assessments.
Testing
Following entry and familiarization session, the subjects were informed 
about testing protocol and basic characteristics (age, height, and 
weight) and blood testing. Thigh mass was measured using previously 
established methods [22] and assessed for perceived muscle soreness. 
Subjects were instructed to warm-up briefly (10 minutes cycling at 
~50 W). Then, they were asked to perform 24 sets of 10 eccentric 
knee extensor repetitions. They actively resisted against the lever 
arm of the Biodex, which forced their leg into flexion with one leg 
(1 minute recovery between sets) at 30°/s on a Biodex System - 3 
(Biodex Medical Systems Inc., New York, USA). The eccentric exercise 
has been shown previously to decrease the range of motion and 
an increased inflammatory response that are hallmarks for muscle 
soreness and damage [23]. All subjects were seated during the exercise, 
and the dynamometer axis of rotation was oriented in alignment 
with their knee, while the force was applied below their knee with a 
padded lever arm. The point of contact between the subject’s lower leg 
and the padded arm was at a fixed distance (relative to the subject’s 
lower limb length), slightly above their ankle. The contractions were 
performed over a range of 60° (130°-70° of flexion, where 180° will 
be a full extension). A range of 60°, to achieve 70° of flexion, will be 
chosen so that the muscle will be exercised over a longer length, and 
result in greater muscle soreness than would be achieved over a smaller 
range, or at shorter muscle lengths [23]. The subjects were instructed 
to extend their knee as the lever arm of the Biodex was raised upward 
(no force required, i.e., passive mode), during the concentric movement 
and verbally encouraged to maximally resist the lowering lever arm of 
the Biodex, during the eccentric movement. Subjects will generate at 
least 50 Nm of torque to start and maintain the downward movement 
to the lever estimating eccentric contraction-induced muscle soreness. 
To further encourage maximal effort, a computer screen was provided 
subjects with a visual feedback of their force production throughout 
the exercise movement. Throughout the exercise protocol eccentric 
peak torque (Nm/kg) and total work (J/kg) data were monitored and 
collected for each set.
Assessments
Subjects were asked to fast overnight for 12 hrs, and approximately 
six teaspoons of fasting venous blood (30 ml) were withdrawn. Blood 
samples were obtained using standard phlebotomy procedures using 
standard sterile venipuncture of an antecubital vein by laboratory 
technician’s trained in phlebotomy in compliance with guidelines 
established by the Texas Department of Health and Human Services, 
USA. Blood samples were taken pre-workout and immediately after the 
damaging bout, at 1 hr, 3 hrs, and 24 hrs post exercise. Serum and whole 
blood samples were collected, micro-centrifuged and assessed for anti-
inflammatory cytokines (IL-10), proinflammatory cytokines (IL-1ra, 
IL-1b, IL-6, and TNF-a) using enzyme-linked immunosorbent assay 
techniques, and safety parameters of kidney function (BUN, creatinine, 
and BUN/creatinine ratio) and differential leukocyte count.
Statistical analysis
The data were represented as a mean ± standard deviation. The data 
of basic characteristics were analyzed by two-way ANOVA followed by 
Bonferroni’s multiple comparisons test. The data of other assessments 
were analyzed by separate repeated measure two-way ANOVA for the 




Basic characteristics of the participants in the group are represented 
in Table 1. There was no significant difference noted at baseline with 
respect to age (placebo - 20.0±1.9 years vs. IBPR 21.0±2.8 years), 
weight (placebo - 89.0±20.0 kg vs. IBPR - 77.0±20.0 kg), and height 
(placebo - 175.0±14.0 cm vs. IBPR - 174.0±10.0 cm).
Effects on anti-inflammatory cytokines, IL-10
The data for effects of supplementation on serum concentrations of 
the anti-inflammatory cytokine, IL-10 is presented in Table 2. Two-way 
ANOVA of data of IL-10 did not show time- or treatment-dependent 
effects. After 24 hrs, serum IL-10 concentration in IBPR group increased 
by 8.95% (pre-workout: 1.84 pg/ml to post-workout-24 hrs: 2.00 pg/ml) 
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whereas placebo showed increase of 1.32% (pre-workout: 1.14 pg/ml 
to post-workout-24 hrs: 1.15 pg/ml).
Effects on proinflammatory cytokines (IL-1rα, IL-1β IL-6, and 
TNF-α)
The data of effects of supplementation on serum concentrations 
of inflammatory cytokines such IL-1rα, IL-1β IL-6, and TNF-α are 
presented in Table 3.
Two-way ANOVA of data of IL-1ra showed significant treatment-
dependent [F (1.76) = 11.81, p=0.001] but not time-dependent effects. 
Serum IL-1ra concentration in IBPR group decreased by 5.56% (pre-
workout: 15.82 pg/ml to post-workout - 0 hr: 14.94 pg/ml) whereas 
placebo showed increase of 68.87% (pre-workout: 22.93 pg/ml to post-
workout - 0 hr: 38.72 pg/ml). After 24 hrs of post-workout, IBPR group 
showed 13.33% decrease (pre-workout: 15.82 pg/ml to post-workout 
- 24 hrs: 13.71 pg/ml) whereas placebo group showed increase 
of 28.08% (pre-workout: 22.93 pg/ml to post-workout - 24 hrs: 
29.37 pg/ml) in serum IL-1ra concentration.
Two-way ANOVA of data of IL-1β showed significant time-dependent 
(F [4,72] = 4.77, p<0.01) but not treatment-dependent effects. 
Serum IL-1b concentration in IBPR group increased by 12.90% (pre-
workout: 0.31 pg/ml to post-workout - 0 hr: 0.35 pg/ml) whereas 
placebo showed increase of 21.2% (pre-workout: 0.33 pg/ml to post-
workout - 0 hr: 0.40 pg/ml). After 24 hrs of post-workout, IBPR group 
showed 1.62% (pre-workout: 0.305 pg/ml to post-workout - 24 hrs: 
0.31 pg/ml) increase whereas placebo group showed increase of 6.36% 
(pre-workout: 0.33 pg/ml to post-workout - 24 hrs: 0.35 pg/ml) in 
serum IL-1b concentration.
Two-way ANOVA of data of IL-6 showed significant time-dependent 
(F [4,72] = 4.033, p<0.01) but not treatment-dependent effects. Serum IL-6 
concentration in IBPR group decreased by 1.6% (pre-workout: 2.19 pg/
ml to post-workout - 0 hr: 2.15 pg/ml) whereas placebo showed increase 
of 43% (pre-workout: 1.73 pg/ml to post-workout - 0 hr: 2.50 pg/ml). 
After 24 hrs of post-workout, IBPR group showed 41% decrease (pre-
workout: 2.19 pg/ml to post-workout - 24 hrs: 1.27 pg/ml) whereas 
placebo group showed increase of 8.3% (pre-workout: 1.73 pg/ml to 
post-workout - 24 hrs: 1.88 pg/ml) in serum IL-6 concentration.
Two-way ANOVA of data of TNF-a did not show time- or treatment-
dependent effects. Serum TNF-a concentration in IBPR group increased 
by 11.9% (pre-workout: 2.04 pg/ml to post-workout - 0 hr: 2.28 pg/ml) 
whereas placebo showed increase of 5.14% (pre-workout: 2.45 pg/ml 
to post-workout - 0 hr: 2.57 pg/ml). After 1 hr of post-workout, IBPR 
group showed 4.67% decrease (pre-workout: 2.04 pg/ml to post-
workout - 1 hr: 1.94 pg/ml) whereas placebo group showed increase of 
1.3% (pre-workout: 2.45 pg/ml to post-workout - 1 hr: 2.48 pg/ml) in 
serum TNF-a concentration.
Effects on kidney function markers
The data of effects of IBPR supplementation on serum concentrations 
of kidney function markers, namely, BUN, serum creatinine, and BUN to 
creatinine ratio are presented in Table 4.
Two-way ANOVA of data of BUN did not show time- or treatment-
dependent effects. Serum BUN concentration in IBPR group increased 
by 0.85% (pre-workout: 14.20 mmol/L to post-workout - 0 hr: 
14.32 mmol/L) whereas placebo showed decrease of 6.64% (pre-
workout: 15.00 mmol/L to post-workout - 0 hr: 14.00 mmol/L). After 24 
hrs of post-workout, IBPR group showed 0.70% increase (pre-workout: 
14.20 mmol/L to post-workout - 24 hrs: 14.30 mmol/L) whereas 
placebo group showed decrease of 6.00% (pre-workout: 15.00 mmol/L 
to post-workout - 24 hrs: 14.10 mmol/L) in serum BUN concentration.
Table 1: Basic characteristics of the participants in the studied 
groups
Parameters Placebo IBPR Significance
Age (years) 20.0±1.90 21.0±2.80 ns
Height (cm) 175.0±14.0 174.0±10.0 ns
Weight (kg) 89.0±20.0 77.0±20.0 ns
Data were represented as mean±SD. The data were analyzed by two-way 
ANOVA followed by Bonferroni’s multiple comparisons test, ns: Not significant
Table 2: Serum concentrations of anti-inflammatory cytokines
Parameters Time Placebo IBPR
IL-10 (pg/ml) T1 (pre-workout) 1.14±0.61 1.84±1.64
T2 (post-workout - 0 hr) 1.10±0.49 1.68±1.51
T3 (post-workout - 1 hr) 1.10±0.44 1.71±1.41
T4 (post-workout - 3 hrs) 1.23±0.45 1.82±1.40
T5 (post-workout - 24 hrs) 1.15±0.44 2.00±1.47
Data were represented as mean±SD. Data were analyzed by two-way repeated 
measure ANOVA. There was no time- or treatment-dependent significance
Table 3: Serum concentrations of proinflammatory cytokines
Parameters Time Placebo IBPR
IL-1rα (pg/ml) T1 (pre-workout) 22.93±17.47 15.82±14.49
T2 (post-workout - 0 hr) 38.72±23.11 14.94±13.70
T3 (post-workout - 1 hr) 32.02±23.52 22.47±22.02
T4 (post-workout - 3 hrs) 34.67±27.29 18.00±14.29
T5 (post-workout - 24 hrs) 29.37±26.17 13.71±11.33
IL-1β (pg/ml) T1 (pre-workout) 0.33±0.23 0.31±0.22
T2 (post-workout - 0 hr) 0.40±0.28 0.35±0.23
T3 (post-workout - 1 hr) 0.40±0.25 0.38±0.25
T4 (post-workout - 3 hrs) 0.37±0.27 0.38±0.32
T5 (post-workout - 24 hrs) 0.35±0.23 0.31±0.25
IL-6 (pg/ml) T1 (pre-workout) 1.73±1.18 2.19±1.90
T2 (post-workout - 0 hr) 2.50±1.53 2.15±1.29
T3 (post-workout - 1 hr) 3.34±2.58 2.11±1.14
T4 (post-workout - 3 hrs) 2.98±1.80 2.03±0.73
T5 (post-workout - 24 hrs) 1.88±1.48 1.27±0.55
TNFα (pg/ml) T1 (pre-workout) 2.45±0.80 2.04±0.46
T2 (post-workout - 0 hr) 2.57±1.10 2.28±0.92
T3 (post-workout - 1 hr) 2.48±1.26 1.94±0.68
T4 (post-workout - 3 hrs) 2.65±1.21 2.26±1.01
T5 (post-workout - 24 hrs) 2.77±1.46 2.27±1.43
Data were represented as mean±SD. Data were analyzed by two-way repeated measure ANOVA. IL-1rα - treatment-dependent significant effects but no significant 
time-dependent effects, IL-1β and IL6 - significant time-dependent effects but no treatment-dependent significant effects, TNF-α - no time- or treatment-dependent 
significant effects, TNF: Tumor necrosis factor
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Two-way ANOVA of data of creatinine showed significant time-
dependent (F [4,72] = 3.22, p<0.05) but not treatment-dependent 
effects. Serum creatinine concentration in IBPR group increased by 4.3% 
(pre-workout: 0.92 mg/dL to post-workout - 0 hr: 0.96 mg/dL) whereas 
placebo showed increase of 0.76% (pre-workout: 0.92 mg/dL to post-
workout - 0 hr: 0.93 mg/dL). After 24 hrs of post-workout, IBPR group 
showed 0.87% decrease (pre-workout: 0.92 mg/dL to post-workout 
- 24 hrs: 0.91 mg/dL) whereas placebo group showed decrease of 1.3% 
(pre-workout: 0.92 mg/dL to post-workout - 24 hrs: 0.91 mg/dL) in 
serum creatinine concentration.
Two-way ANOVA of data of BUN to creatinine ratio did not show 
time- or treatment-dependent effects. BUN to creatinine ratio 
in IBPR group decreased by 0.4% (pre-workout: 15.7 to post-
workout - 0 hr: 15.3) whereas placebo showed a decrease of 1% 
(pre-workout: 16.1 to post-workout: 15.1). After 24 hrs of post-
workout, IBPR group showed 0.5% increase (pre-workout: 15.7 
to post-workout - 24 hrs: 16.2) whereas placebo group showed 
decrease of 0.7% (pre-workout: 16.1 to post-workout - 24 hrs: 15.4) 
in BUN to creatinine ratio.
Effects on differential leukocyte count
The data of effects of supplementation on differential leukocyte 
count are presented in Table 5. Two-way ANOVA of data of none of 
the differential leukocyte count (neutrophils, eosinophils basophils 
lymphocytes, and monocytes) showed time- or treatment-dependent 
effects.
DISCUSSION
The objective of this study was to evaluate the efficacy of IBPR 
supplementation on inflammation associated with an acute physical 
activity such as eccentric exercise in non-resistance trained young 
subjects. The effect of 14-day intake of 450 mg IBPR showed a reduction 
in the inflammatory markers induced by eccentric knee extensor 
repetitions in non-resistance young subjects. The major component of 
IBPR is derived from fenugreek seed extract and has the characteristic 
Table 4: Parameters of kidney function parameters
Parameters Time Placebo IBPR
BUN (mmol/L) T1 (pre-workout) 15.00±5.98 14.20±4.08
T2 (post-workout - 0 hr) 14.00±5.01 14.32±3.56
T3 (post-workout - 1 hr) 14.10±6.12 13.70±3.89
T4 (post-workout - 3 hrs) 14.55±6.00 14.45±3.62
T5 (post-workout - 24 hrs) 14.10±4.91 14.30±2.83
Serum Creatinine (mg/dL) T1 (pre-workout) 0.92±0.19 0.92±0.20
T2 (post-workout - 0 hr) 0.93±0.22 0.96±0.18
T3 (post-workout - 1 hr) 0.93±0.21 0.92±0.20
T4 (post-workout - 3 hrs) 0.95±0.20 0.99±0.20
T5 (post-workout - 24 hrs) 0.91±0.19 0.91±0.19
BUN to creatinine ratio T1 (pre-workout) 16.1±3.93 15.7±4.00
T2 (post-workout - 0 hr) 15.1±2.89 15.3±3.20
T3 (post-workout - 1 hr) 14.9±4.01 14.9±3.51
T4 (post-workout - 3 hrs) 15.2±3.43 14.8±3.62
T5 (post-workout - 24 hrs) 15.4±3.20 16.2±1.93
Data were represented as mean±SD. Data were analyzed by two-way repeated measure ANOVA. BUN and BUN to creatinine ratio - no time- or treatment-dependent 
significant effects, serum creatinine - significant time-dependent effects but no treatment-dependent significant effects. BUN: Blood urea nitrogen
Table 5: Differential leukocyte count
Parameters Time Placebo IBPR
Neutrophil T1 (pre-workout) 58.05±8.19 55.94±14.25
T2 (post-workout - 0 hr) 55.38±19.38 66.63±9.11
T3 (post-workout - 1 hr) 61.11±18.16 64.40±17.22
T4 (post-workout - 3 hrs) 51.95±21.88 65.93±9.55
T5 (post-workout - 24 hrs) 52.37±12.86 54.64±8.69
Eosinophil T1 (pre-workout) 1.54±0.57 3.24±2.11
T2 (post-workout - 0 hr) 1.50±0.59 2.42±2.07
T3 (post-workout - 1 hr) 1.38±0.87 3.36±3.44
T4 (post-workout - 3 hrs) 2.31±1.80 2.47±1.51
T5 (post-workout - 24 hrs) 2.69±1.86 3.65±2.86
Basophil T1 (pre-workout) 0.43±0.13 0.00±0.00
T2 (post-workout - 0 hr) 0.40±0.23 0.30±0.13
T3 (post-workout - 1 hr) 0.37±0.22 0.37±0.25
T4 (post-workout - 3 hrs) 0.47±0.34 0.35±0.15
T5 (post-workout - 24 hrs) 0.35±0.18 0.44±0.24
Lymphocyte T1 (pre-workout) 33.18±7.52 30.92±7.09
T2 (post-workout - 0 hr) 33.04±15.32 24.29±7.77
T3 (post-workout - 1 hr) 30.97±16.41 27.09±12.94
T4 (post-workout - 3 hrs) 37.02±16.78 26.24±8.65
T5 (post-workout - 24 hrs) 36.99±11.21 35.17±7.21
Monocyte T1 (pre-workout) 6.87±2.34 6.50±1.06
T2 (post-workout - 0 hr) 6.95±2.88 6.06±1.15 
T3 (post-workout - 1 hr) 6.17±2.45 4.79±3.20
T4 (post-workout - 3 hrs) 8.24±5.23 4.99±2.44
T5 (post-workout - 24 hrs) 7.61±2.86 6.10±3.07
Data were represented as mean±SD. Data were analyzed by two-way repeated measure ANOVA. None of the parameter (neutrophils, eosinophils basophils lymphocytes, 
and monocytes) has no time- or treatment-dependent significance
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smell of fenugreek seeds. Therefore, curcumin and cinnamon are added 
in minor quantities (25 mg each) for blinding and placebo design. The 
doses and duration of curcumin [20] and cinnamon [21] are below 
reported efficacious doses and durations against inflammatory markers 
and so nonactive. Therefore, the anti-inflammatory efficacy that was 
observed in this study can be attributed to the major component, a 
glycoside based standardized fenugreek seed extract, which constitute 
88.89% of IBPR. The IBPR supplementation was found to be safe and 
well tolerated for all subjects during this study. No adverse side effects 
were reported by any of the participants, nor were any clinical safety 
markers or hematological variables significantly altered (p>0.05) 
demonstrating supplement appears safe when taken over 14-day 
before exercise bout. These results are in line with reported safety 
profile of the glycoside based standardized fenugreek seed extracts in 
human subjects [24] as well as animals [25,26].
Following 14-day of supplement dosage, inflammatory markers were 
assessed after an exercise bout. The serum level of the inflammatory 
marker, IL6 in IBPR supplemented group was significantly less than 
placebo at 1 hr and 3 hrs post-exercise which supports anti-inflammatory 
properties of IBPR. IL-6 increases hepatic glucose production during 
exercise and lipolysis in adipose tissue [27]. The increase in IL-6 also 
enhances insulin action and sensitivity [28] unlike TNF-α-induced 
insulin resistance [29]. The absence of classical proinflammatory 
cytokines (TNF-α and IL-1β) in the exercise-induced cytokine cascade 
causes an increase of IL-6, IL-1ra, IL-19, and sTNF-R [30], creating 
an anti-inflammatory environment. It appears that exercise inhibits 
TNF-α directly by IL-6 [31] and indirectly via epinephrine [32]. The 
down-regulation of TNF-α induced by skeletal muscle-derived IL-6 may 
also participate in mediating the atheroprotective effect of physical 
activity [33]. Findings of this study of lowered numbers of leukocyte 
counts after eccentric exercise support the past report of exercise-
induced lowering of blood leukocyte count during and following 
exercise in healthy and moderately fit males [34]. These findings were 
consistent also consistent with the published reports from animal 
studies in arthritic condition, where a reduction in an acute-phase 
inflammatory response, after daily intake of fenugreek seed extract 
was observed [35,36]. Considerable evidence supported the anti-
inflammatory properties of fenugreek seed extract administration 
through decreased cytokine gene expression in Freund’s complete 
adjuvant-induced arthritis in rats [37]. Fenugreek seed extract showed 
a significant reduction in proinflammatory cytokines in vitro [10]. 
This study supports probable mechanism of anti-inflammatory action 
of fenugreek seed extracts that is demonstrated in the previous 
reports [35-37].
The strengths of the study include homogenous population between 
the study group and a comprehensive assessment of subjective and 
objective variables before, during and after each exercise bout. We 
have observed increased trend for anti-inflammatory cytokine (IL-
10) and decreased trend toward proinflammatory cytokines (IL-1rα, 
IL-1β IL-6, and TNF-α) with IBPR supplementation. However, the 
small sample size and large variability in the inflammatory cytokine 
responses may be limiting factors for statistical significance. This study 
was a comparison of acute exercise responses, where effects of training 
adaptations to the eccentric knee extensions were not seen. Because 
of the greater inflammatory response with eccentric knee extensions, 
participants transitions slowly with progressive loading, which is 
important for untrained persons, older adults or individuals with 
a recent musculoskeletal injury. Therefore, the data of this study are 
useful for future studies for exploration of IBPR as a dietary supplement 
for subjects with RX in a wide variety of populations.
CONCLUSION
The supplementation of IBPR, a proprietary blend rich in glycoside 
based standardized fenugreek seed extract, showed efficacy and safety 
in young subjects for the reduction of eccentric exercise-induced 
inflammatory markers.
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